Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018.
Publication
, Journal Article
Garcia-Jeldes, HF; Mitchell, R; McGeer, A; Rudnick, W; Amaratunga, K; Vallabhaneni, S; Lockhart, SR; CNISP C. auris Interest Group; Bharat, A
Published in: Antimicrob Resist Infect Control
June 10, 2020
To identify the prevalence of C. auris in Canadian patients who are potentially at risk for colonization, we screened 488 patients who were either hospitalized abroad, had a carbapenemase-producing organism (CPO), or were in units with high antifungal use. Two patients were colonized with C. auris; both had received healthcare in India and had a CPO. Among 35 patients who had recently received healthcare in the Indian subcontinent and were CPO colonized or infected, the prevalence of C. auris was 5.7%.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Antimicrob Resist Infect Control
DOI
EISSN
2047-2994
Publication Date
June 10, 2020
Volume
9
Issue
1
Start / End Page
82
Location
England
Related Subject Headings
- beta-Lactamases
- Travel
- Prevalence
- Middle Aged
- Male
- India
- Humans
- Female
- Candidiasis
- Candida
Citation
APA
Chicago
ICMJE
MLA
NLM
Garcia-Jeldes, H. F., Mitchell, R., McGeer, A., Rudnick, W., Amaratunga, K., Vallabhaneni, S., … Bharat, A. (2020). Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018. Antimicrob Resist Infect Control, 9(1), 82. https://doi.org/10.1186/s13756-020-00752-3
Garcia-Jeldes, Hector Felipe, Robyn Mitchell, Allison McGeer, Wallis Rudnick, Kanchana Amaratunga, Snigdha Vallabhaneni, Shawn R. Lockhart, CNISP C. auris Interest Group, and Amrita Bharat. “Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018.” Antimicrob Resist Infect Control 9, no. 1 (June 10, 2020): 82. https://doi.org/10.1186/s13756-020-00752-3.
Garcia-Jeldes HF, Mitchell R, McGeer A, Rudnick W, Amaratunga K, Vallabhaneni S, et al. Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018. Antimicrob Resist Infect Control. 2020 Jun 10;9(1):82.
Garcia-Jeldes, Hector Felipe, et al. “Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018.” Antimicrob Resist Infect Control, vol. 9, no. 1, June 2020, p. 82. Pubmed, doi:10.1186/s13756-020-00752-3.
Garcia-Jeldes HF, Mitchell R, McGeer A, Rudnick W, Amaratunga K, Vallabhaneni S, Lockhart SR, CNISP C. auris Interest Group, Bharat A. Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018. Antimicrob Resist Infect Control. 2020 Jun 10;9(1):82.
Published In
Antimicrob Resist Infect Control
DOI
EISSN
2047-2994
Publication Date
June 10, 2020
Volume
9
Issue
1
Start / End Page
82
Location
England
Related Subject Headings
- beta-Lactamases
- Travel
- Prevalence
- Middle Aged
- Male
- India
- Humans
- Female
- Candidiasis
- Candida